昆明人流医院哪家好"昆明 哪家人流医院,昆明比较好的正规流产医院,昆明有哪个好的人流医院,昆明六十天的宝宝可以药流吗,昆明瞻园附近 打胎多少钱,做人流的好医院 昆明,昆明市打胎好多钱

BEIJING, Feb. 21 (Xinhua) -- China's domestic air travelers, as well as international passengers in and out of China, will be the biggest boost to airline industry growth over the next four years, according to an industry outlook report by the International Air Transport Association (IATA) Monday.Of the world's expected 800 million new travelers by 2014, about 181 million new passengers will come from China's domestic air routes, while another 33 million will be passengers flying to or from China via international routes, IATA said.China's 181 million domestic air passengers growth will lift the country's domestic passenger throughput to 379 million by 2014, only behind the United States in the world's aviation traveler volume ranking, according to IATA.The United States will remain the largest single country market for domestic passengers, with 671 million domestic air travelers and international passengers by then, according to IATA's forecast.The world's air travelers will top 3.3 billion by 2014, up by 800 million from the 2.5 billion in 2009, while world air cargo will rise to 38 million tonnes from 26 million tonnes in 2009."The forecast indicates that the world will continue to become more mobile. This creates enormous opportunities but also presents some challenges," Giovanni Bisignani, IATA' s Director General and CEO, said in the outlook report."We will need even more efficient air traffic management, airport facilities and security programs," he said, adding the shadow of the global economic recession is expected to remain over parts of the industry for some time to come.He said lingering consumer debt, high unemployment and austerity measures will dampen growth rates in Europe and North America, shifting the industry's focus eastwards.By 2014, 1 billion people will travel by air in the Asia-Pacific region, accounting for 30 percent of the global total, up from 26 percent in 2009, he added.

SAN FRANCISCO, April 4 (Xinhua) -- Web exploit toolkits, or " packaged" attack frameworks that can be traded online, are rapidly growing as the top cybercrime weapon due to ease of use and high success rate, a new report has found."When it comes to conducting online crime, exploit toolkits are the weapon of choice for many cyber criminals," said the "2010 Top Cyber Security Risks Report" published by Hewlett-Packard Co. (HP) on Monday.The trend started in 2006 with the release of WebAttacker, considered by many to be the first modern day web exploit toolkit, according to the report.An emerging trend ensued and soon took off, and today the Internet is subjected to hundreds of exploits originating from these toolkits."With the ever-increasing, web-based criminal activity, the number of exploit toolkits has skyrocketed and shows no signs of slowing down," the report stated.Though protecting against attacks originated with web exploit toolkits is becoming increasingly difficult, there are ways to minimize the risk of infection, said the report, noting that one of the most effective defenses is to install patches onto host systems.The report also found that while the number of attacks against known vulnerabilities continues to rise, the number of discovered vulnerabilities has plateaued in 2010."We've discovered that rather than investing resources to uncover new exploits, attackers are focused on current, unpatched vulnerabilities in web applications, social networking sites and Web 2.0 interfaces," Mike Dausin, a manager at HP Digital Vaccine Labs, said in a statement.Data from the report showed that nearly half of all reported vulnerabilities exist in web applications, and third-party plug- ins to content management systems have become the leading cause of web application vulnerabilities.

WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.

BEIJING, Feb. 5 (Xinhua) -- China's meteorological authority said Saturday that a cold snap would sweep north China over the next few days, bringing down temperatures and carrying gusty winds.Temperatures in some parts of Xinjiang Uygur Autonomous Region, Inner Mongolia Autonomous Region and northeast China will drop 4 to 6 degrees Celsius over the weekend, the National Meteorological Center (NMC) said in a statement on its website.In most areas north to the Huaihe River, the temperatures will go down 4 to 6 degrees Celsius, or even 8 to 10 degrees Celsius in some parts of the areas between Monday and Tuesday.The cold front would then move southward to affect more areas in the eastern and southern parts of the country.The NMC said some areas in northern and western Xinjiang Uygur Autonomous Region, the eastern part of Inner Mongolia, Sichuan Basin and most of the northeast China, the western parts of the areas south to the Yangtze River will see light to moderate snow or sleet in the forthcoming three days.Fog continued to shroud south China Saturday, reducing visibility to less than 200 meters in parts of Hunan, Hubei, Jiangxi, Sichuan and Fujian provinces, as well as Chongqing City.

VIENNA, March 18 (Xinhua) -- The 26th Annual Congress of the European Association of Urology (2011 EAU congress) kicked off on Friday at the Vienna Austria Center in the Austrian capital Vienna.About 14,000 doctors, experts, scholars and representatives of pharmaceutical enterprises in the field of urology from more than 80 countries took part in the event, which will last till Tuesday.The EAU congress is Europe's largest fair in the field of urology. This is the third time for Vienna to host the event.The EAU congress aims to review technical innovation and technological progress in the field of urology and related subspecialties, discuss new theories, new technologies and new diagnostic methods of urological clinical trials, optimize the risk management of urological disease, and enhance doctors' practical knowledge and skills by educational activities.It also provides an important platform for related pharmaceutical, medical equipments and medical consumables manufacturers to present their latest products and technologies, and creates the opportunity of face-to-face communication between suppliers and consumers.The highlights of this year's EAU congress include the discussion of state-of-the-art kidney imaging and the application of ultrasound, computerized tomography (CT-scan) and magnetic resonance imaging (MRI).Participants are also expected to give a timely overview on the role of imaging, focal therapy and kidney biopsy in the management and follow-up of small renal masses, as well as the use of imaging in the management of urinary incontinence and other pelvic urinary pathologies.Congress organizers said that more than 200 presentations and seminars are scheduled during the five-day meeting, with an estimated 400 speakers unveiling their latest findings.